Track & Trace Requirement's Surprising Upside: Industry Efficiency
Executive Summary
As November deadline looms, firms experience better receiving, communications thanks to upgrades, but FDA still waiting.
You may also be interested in...
Generic Drug Surveillance Could Be Enhanced By Dispensers Recording NDC, Manufacturer Data
US FDA’s MedWatch program could benefit from additional data capture – and generic and biosimilar reputations could too.
Generic Drug Surveillance Could Be Enhanced By Dispensers Recording NDC, Manufacturer Data
US FDA’s MedWatch program could benefit from additional data capture – and generic and biosimilar reputations could too.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.